Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP

Professor of Pharmacy Practice
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 16. Chang E, Ballard K E, Johnson P N, Nandyal R, Miller J L. Azithromycin for Eradication of Ureaplasma and Prevention of Bronchopulmonary Dysplasia in Preterm Neonates in the Neonatal Intensive Care Unit. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2023; 28 : 10-19
17. Hintze T D, Miller J L, Neely S, Lim S Y, Gupta N, Johnson P N. Characterization of early versus late opioid iatrogenic withdrawal syndrome in critically ill children transitioning from fentanyl -infusions to methadone. Journal of opioid management. 2023; 19 : 43-56
18. Bradford C V, Fung M Y, Wang A, Benefield E C, Bashqoy F, Neely S, Johnson P N. Delirium Assessment Treatment Strategies in Critically Ill Pediatric Patients: A Pediatric Pharmacy Association Practice-Based Research Network Survey Study. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2023; 28 : 540-552
19. Stephens K, Miller J L, Harkin M, Neely S, Haws L, Johnson P N. Effect of Phytonadione on Correction of Coagulopathy in Pediatric Patients With Septic Shock. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2023; 28 : 423-429
20. Bradford C, Miller J L, Harkin M, Chaaban H, Neely S, Johnson P N. Melatonin Use in Infants Admitted to Intensive Care Units. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2023; 28 : 635-642
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 1. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Avery Parman). Date: 2024.
2. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Dom Ropp). Date: 2023.
3. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Eugenie Chang). Date: 2023.
4. Society of Critical Care Medicine Presidential Citation. Date: 2022.
5. Oklahoma Foundation for Excellence. Oklahoma Medal for Excellence Finalist in Teaching and Administration. Date: 2022.
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results